2 hours ago
1
Heron Therapeutics (NASDAQ:HRTX) Friday reported the completion of a comprehensive capital restructuring designed to enhance the company's financial flexibility, reduce total debt, and support long-term growth.
A new senior credit facility with Hercules Capital (HTGC) due in 2030, which provides $110.0 million
English (US) ·